Barbara E. Mahon, MD

Adjunct Assistant Professor, Epidemiology

Barbara Mahon
617.358.3728
715 Albany St Talbot Building

Biography

Dr. Mahon received her MD and clinical training in pediatrics from the University of California, San
Francisco and her MPH from the University of California, Berkeley. She trained in CDC’s Epidemic
Intelligence Service (EIS). Dr. Mahon is deputy chief of the Enteric Diseases Epidemiology and
Surveillance Branch at the Centers for Disease Control and Prevention (CDC). The branch is responsible
for national surveillance for enteric diseases. It conducts epidemiologic studies of the burden, trends,
and food source attribution of foodborne diseases caused by Listeria , Salmonella, and E. coli O157,
among other pathogens. The branch’s work also focuses on vulnerable populations, including older
adults, young children, and other groups, with the goal of creating knowledge needed to protect people
by preventing disease. Dr. Mahon has a broad background in infectious disease epidemiology, having
worked on foodborne diseases, vaccine-preventable diseases, and sexually transmitted diseases in
academic and industry positions as well as in government.

Other Positions

  • Adjunct Assistant Professor, General Pediatrics, Pediatrics, Boston University School of Medicine

Education

  • University of California San Francisco, MD
  • University of California, Berkeley, MPH
  • Harvard University, AB

Publications

  • Published on 5/18/2018

    Fombah AE, Goldstein ST, Jarrett OD, Jalloh MI, El-Khorazaty J, Lisk DR, Legardy-Williams J, Pratt DA, George PM, Russell JBW, Schrag SJ, Dawson P, Deen GF, Carr W, Lindblad R, James F, Bah MM, Yillia JF, Sandy JD, Turay PE, Conteh MA, Slutsker L, Mahon BE, Samai M, Seward JF. Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). J Infect Dis. 2018 May 18; 217(suppl_1):S75-S80. PMID: 29788342.

    Read at: PubMed
  • Published on 5/18/2018

    Schuchat A, Seward JF, Goldstein ST, Mahon BE. Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). J Infect Dis. 2018 May 18; 217(suppl_1):S1-S5. PMID: 29788344.

    Read at: PubMed
  • Published on 5/18/2018

    Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A. The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV?G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak. J Infect Dis. 2018 May 18; 217(suppl_1):S6-S15. PMID: 29788345.

    Read at: PubMed
  • Published on 5/18/2018

    Conteh MA, Goldstein ST, Wurie HR, Gidudu J, Lisk DR, Carter RJ, Seward JF, Hampton LM, Wang D, Andersen LE, Arvay M, Schrag SJ, Dawson P, Fombah AE, Petrie CR, Feikin DR, Russell JBW, Lindblad R, Kargbo SAS, Samai M, Mahon BE. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola. J Infect Dis. 2018 May 18; 217(suppl_1):S33-S39. PMID: 29788347.

    Read at: PubMed
  • Published on 5/18/2018

    Kabineh AK, Carr W, Motevalli M, Legardy-Williams J, Vincent W, Mahon BE, Samai M. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience. J Infect Dis. 2018 May 18; 217(suppl_1):S56-S59. PMID: 29788349.

    Read at: PubMed
  • Published on 4/15/2018

    Scallan E, Griffin PM, McLean HQ, Mahon BE. Hospitalisations due to bacterial gastroenteritis: A comparison of surveillance and hospital discharge data. Epidemiol Infect. 2018 Jun; 146(8):954-960. PMID: 29655383.

    Read at: PubMed
  • Published on 12/27/2017

    Yu PA, Lin NH, Mahon BE, Sobel J, Yu Y, Mody RK, Gu W, Clements J, Kim HJ, Rao AK. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin. Clin Infect Dis. 2017 Dec 27; 66(suppl_1):S57-S64. PMID: 29293928.

    Read at: PubMed
  • Published on 12/14/2017

    Patrick ME, Henao OL, Robinson T, Geissler AL, Cronquist A, Hanna S, Hurd S, Medalla F, Pruckler J, Mahon BE. Features of illnesses caused by five species of Campylobacter, Foodborne Diseases Active Surveillance Network (FoodNet) - 2010-2015. Epidemiol Infect. 2018 Jan; 146(1):1-10. PMID: 29237513.

    Read at: PubMed
  • Published on 12/1/2017

    Narra R, Sobel J, Piper C, Gould D, Bhadelia N, Dott M, Fiore A, Fischer WA, Frawley MJ, Griffin PM, Hamilton D, Mahon B, Pillai SK, Veltus EF, Tauxe R, Jhung M. CDC Safety Training Course for Ebola Virus Disease Healthcare Workers. Emerg Infect Dis. 2017 Dec; 23(13). PMID: 29154748.

    Read at: PubMed
  • Published on 10/30/2017

    Geissler AL, Bustos Carrillo F, Swanson K, Patrick ME, Fullerton KE, Bennett C, Barrett K, Mahon BE. Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012. Clin Infect Dis. 2017 Oct 30; 65(10):1624-1631. PMID: 29020144.

    Read at: PubMed

View 92 more publications: View full profile at BUMC

View all profiles